{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T12:41:18Z","timestamp":1725367278424},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"DOI":"10.1093\/ckj\/sfx033","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T23:33:24Z","timestamp":1491521604000},"page":"594-599","source":"Crossref","is-referenced-by-count":19,"title":["Late-onset Bartter syndrome type II"],"prefix":"10.1093","volume":"10","author":[{"given":"Benjamin","family":"Gollasch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoland-Marie","family":"Anistan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sima","family":"Canaan-K\u00fchl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maik","family":"Gollasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,5,8]]},"reference":[{"key":"key\n\t\t\t\t20171011233046_sfx033-B1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ng1096-152","article-title":"Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK","volume":"14","year":"1996","journal-title":"Nature Genet"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-0-12-449851-8.00013-9","volume-title":"Genetic Diseases of the Kidney","year":"2009"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1442-200X.2012.03716.x","article-title":"Expanding the spectrum of genetic mutations in antenatal Bartter syndrome type II","volume":"55","year":"2013","journal-title":"Pediatr Int"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B4","first-page":"91","article-title":"Nephrocalcinosis as adult presentation of Bartter syndrome type II","volume":"72","year":"2014","journal-title":"Neth J Med"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2215\/CJN.11311111","article-title":"Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment","volume":"7","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000345801","article-title":"Typical features of amelogenesis imperfecta in two patients with Bartter\u2019s syndrome","volume":"2","year":"2012","journal-title":"Nephron Extra"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B7","doi-asserted-by":"crossref","first-page":"15298","DOI":"10.1073\/pnas.96.26.15298","article-title":"pH gating of ROMK (K(ir)1.1) channels: control by an Arg-Lys-Arg triad disrupted in antenatal Bartter syndrome","volume":"96","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/HYPERTENSIONAHA.108.127993","article-title":"Gitelman syndrome","volume":"53","year":"2009","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B9","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1056\/NEJMoa1507629","article-title":"Polyhydramnios, transient antenatal Bartter's syndrome, and MAGED2 mutations","volume":"374","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B10","article-title":"Genetic causes of hypomagnesemia, a clinical overview","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B11","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/nprot.2015.124","article-title":"Next-generation diagnostics and disease-gene discovery with the Exomiser","volume":"10","year":"2015","journal-title":"Nat Protoc"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B12","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/01.HYP.37.6.1458","article-title":"Mutations in the Na-Cl cotransporter reduce blood pressure in humans","volume":"37","year":"2001","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B13","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/BF01710854","article-title":"Regulation der Reninsekretion beim Bartter-Syndrom","volume":"46","year":"1968","journal-title":"Klin Wschr"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B14","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/ndt\/gfn689","article-title":"Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome","volume":"24","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B15","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/j.1523-1755.2004.00564.x","article-title":"Effect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young rat","volume":"65","year":"2004","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B16","doi-asserted-by":"crossref","first-page":"p73","DOI":"10.1159\/000094001","article-title":"Bartter syndromes and other salt-losing tubulopathies","volume":"104","year":"2006","journal-title":"Nephron Physiol"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B17","first-page":"858","article-title":"Bartter syndrome: benefits and side effects of long-term treatment","volume":"19","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B18","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2214\/ajr.152.6.1251","article-title":"Hypercalciuric Bartter syndrome: resolution of nephrocalcinosis with indomethacin","volume":"152","year":"1989","journal-title":"AJR Am J Roentgenol"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B19","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s00467-006-0252-x","article-title":"Nephrotoxicity with cyclooxygenase 2 inhibitor use in children","volume":"21","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/qjmed\/hcr095","article-title":"Does hypokalaemia cause nephropathy? An observational study of renal function in patients with Bartter or Gitelman syndrome","volume":"104","year":"2011","journal-title":"QJM"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0002-9343(62)90214-0","article-title":"Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome","volume":"33","year":"1962","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ckj\/sfv154","article-title":"Kaliopenic nephropathy revisited","volume":"9","year":"2016","journal-title":"Clin Kidney J"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s10157-011-0431-3","article-title":"A novel compound heterozygous ROMK mutation presenting as late onset Bartter syndrome associated with nephrocalcinosis and elevated 1,25(OH)(2) vitamin D levels","volume":"15","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/MNH.0b013e32833b7125","article-title":"Claudin-16 and claudin-19 function in the thick ascending limb","volume":"19","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B25","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/ckj\/sfv081","article-title":"Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: clinical and molecular characteristics","volume":"8","year":"2015","journal-title":"Clin Kidney J"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B26","first-page":"15","article-title":"A CD2AP mutation associated with focal segmental glomerulosclerosis in young adulthood","volume":"9","year":"2016","journal-title":"Clin Med Insights Case Rep"},{"key":"key\n\t\t\t\t20171011233046_sfx033-B27","first-page":"2555","article-title":"Identification of a novel mutation in RIPK4 in a kindred with phenotypic features of Bartsocas-Papas and CHAND syndromes","volume":"167A","year":"2015","journal-title":"Am J Med Genet Part A"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/10\/5\/594\/20385828\/sfx033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T23:30:58Z","timestamp":1507764658000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ckj\/article\/10\/5\/594\/3806651\/Lateonset-Bartter-syndrome-type-II"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,8]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,8]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfx033","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10]]},"published":{"date-parts":[[2017,5,8]]}}}